Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
Pilot study. The primary end point is the evaluation the efficacy of treatment with
atorvastatin compared to colchicine for the decrease of high sensitivity troponin I levels in
patients with rheumatoid arthritis with severe activity according of the Disease Activity
Score 28 (DAS 28> 5.1), through a randomized controlled clinical trial blinded to the
rheumatologist and the cardiologist who will carry out the evaluation of the patient.